Latest trend in litigation nationwide: Danish pharmaceutical manufacturer Novo Nordisk and its subsidiaries, sued in the United States for dramatically adverse effects of Ozempic and Wegovy. At issue is the relative safety of two medications that were originally approved for treating different yet closely related (diabetes and cardiovascular recovery) maladies, but have been found dramatically
